Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$460,770
-$94,877 QoQ
Shares Held
19,135
-3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#1,809
of 2,821 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEIGH BALDWIN & CO., LLC holds $5,076,288 across 8 Drug Manufacturers - General names. PFE ranks #6 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,112 | $1,333,766 | |
| 2 | MRK |
Merck & Co., Inc.
|
5,407 | $694,799 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
4,769 | $602,515 | |
| 4 | JNJ |
Johnson & Johnson
|
2,262 | $574,480 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
9,200 | $530,104 | |
| 6 | PFE |
Pfizer Inc
This page
|
19,135 | $460,770 | |
| 7 | ABBV |
AbbVie Inc.
|
1,761 | $443,138 | |
| 8 | AMGN |
Amgen Inc
|
1,206 | $436,716 |
All Filings in PFE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $460,770 | 19,135 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $555,647 | 19,788 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $481,466 | 19,336 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,612,501 | 63,285 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,585,296 | 65,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,638,129 | 64,646 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,725,617 | 65,044 | Shares | Sole | 2025-02-25 | |
| No filing history on record for this holder in this stock. | ||||||